GTS Securities LLC bought a new stake in Itron, Inc. (NASDAQ:ITRI - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 2,650 shares of the scientific and technical instruments company's stock, valued at approximately $288,000.
Several other institutional investors and hedge funds also recently bought and sold shares of the company. Norges Bank purchased a new position in shares of Itron during the 4th quarter worth approximately $64,615,000. Bowen Hanes & Co. Inc. acquired a new position in Itron during the fourth quarter worth $27,486,000. Raiffeisen Bank International AG purchased a new position in shares of Itron during the fourth quarter worth $27,619,000. Wellington Management Group LLP grew its stake in shares of Itron by 180.7% in the fourth quarter. Wellington Management Group LLP now owns 333,363 shares of the scientific and technical instruments company's stock valued at $36,197,000 after buying an additional 214,600 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership grew its stake in shares of Itron by 85.7% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 425,484 shares of the scientific and technical instruments company's stock valued at $46,199,000 after buying an additional 196,396 shares in the last quarter. 96.19% of the stock is currently owned by institutional investors and hedge funds.
Itron Price Performance
Shares of ITRI traded up $2.44 during mid-day trading on Friday, hitting $116.15. The company's stock had a trading volume of 649,684 shares, compared to its average volume of 577,910. The company has a current ratio of 3.36, a quick ratio of 2.83 and a debt-to-equity ratio of 0.91. Itron, Inc. has a 1-year low of $90.11 and a 1-year high of $124.90. The firm has a market capitalization of $5.30 billion, a P/E ratio of 23.80, a P/E/G ratio of 0.81 and a beta of 1.31. The firm has a 50-day simple moving average of $106.85 and a 200 day simple moving average of $107.62.
Itron (NASDAQ:ITRI - Get Free Report) last issued its earnings results on Thursday, May 1st. The scientific and technical instruments company reported $1.52 earnings per share for the quarter, topping the consensus estimate of $1.30 by $0.22. The company had revenue of $607.15 million for the quarter, compared to analyst estimates of $608.86 million. Itron had a net margin of 9.37% and a return on equity of 19.03%. The firm's revenue for the quarter was up .6% compared to the same quarter last year. During the same period in the prior year, the business posted $1.24 earnings per share. Analysts predict that Itron, Inc. will post 5.33 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Several research firms have commented on ITRI. Wall Street Zen upgraded shares of Itron from a "hold" rating to a "buy" rating in a research note on Saturday, May 24th. Piper Sandler dropped their target price on Itron from $124.00 to $121.00 and set a "neutral" rating on the stock in a report on Monday, May 5th. Canaccord Genuity Group raised their price target on Itron from $130.00 to $132.00 and gave the company a "buy" rating in a research note on Wednesday, February 26th. Oppenheimer upped their price objective on Itron from $124.00 to $131.00 and gave the stock an "outperform" rating in a research report on Wednesday, February 26th. Finally, Guggenheim restated a "buy" rating and set a $133.00 target price on shares of Itron in a research note on Thursday, April 17th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $127.36.
Read Our Latest Stock Analysis on ITRI
Insiders Place Their Bets
In other Itron news, Director Mary C. Hemmingsen sold 5,150 shares of the firm's stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $108.70, for a total transaction of $559,805.00. Following the sale, the director now directly owns 952 shares of the company's stock, valued at $103,482.40. This trade represents a 84.40% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Donald L. Reeves III sold 529 shares of Itron stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $114.95, for a total transaction of $60,808.55. Following the completion of the sale, the senior vice president now directly owns 20,151 shares of the company's stock, valued at $2,316,357.45. The trade was a 2.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 8,086 shares of company stock worth $897,298. Insiders own 1.51% of the company's stock.
Itron Company Profile
(
Free Report)
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
See Also

Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.